MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631,184 | +52.9% | 14,490 | +26.9% | 0.01% | +66.7% |
| Q2 2023 | $412,677 | -5.0% | 11,422 | -2.2% | 0.00% | -25.0% |
| Q1 2023 | $434,262 | -12.7% | 11,680 | +6.3% | 0.00% | -20.0% |
| Q4 2022 | $497,685 | -32.6% | 10,984 | +4.0% | 0.01% | -37.5% |
| Q3 2022 | $738,000 | +4.4% | 10,563 | +0.4% | 0.01% | +14.3% |
| Q2 2022 | $707,000 | -17.7% | 10,526 | +0.7% | 0.01% | 0.0% |
| Q1 2022 | $859,000 | -39.8% | 10,448 | +7.4% | 0.01% | -36.4% |
| Q4 2021 | $1,427,000 | -17.8% | 9,726 | -0.8% | 0.01% | -21.4% |
| Q3 2021 | $1,735,000 | +11.5% | 9,808 | +1.8% | 0.01% | +7.7% |
| Q2 2021 | $1,556,000 | -11.3% | 9,635 | -6.0% | 0.01% | -13.3% |
| Q1 2021 | $1,755,000 | -4.8% | 10,246 | +22.0% | 0.02% | -11.8% |
| Q4 2020 | $1,844,000 | +29.8% | 8,396 | -1.9% | 0.02% | +21.4% |
| Q3 2020 | $1,421,000 | +95.2% | 8,559 | +34.2% | 0.01% | +40.0% |
| Q2 2020 | $728,000 | +57.2% | 6,379 | +6.0% | 0.01% | +25.0% |
| Q1 2020 | $463,000 | – | 6,018 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |